| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | EP1185316A1 Devices and compounds for treating arterial restenosis |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185305A1 Ligand-conjugated oligomeric compounds |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185303A1 Inhibition of gastric acid production and/or secretion |
| 03/13/2002 | EP1185302A2 Specifically targeted catalytic antagonists and uses thereof |
| 03/13/2002 | EP1185298A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185296A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185295A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 03/13/2002 | EP1185294A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 03/13/2002 | EP1185293A2 Il6ril6 chimera for the treatment of neurodegenerative diseases |
| 03/13/2002 | EP1185292A2 Use of interleukin-11 to treat hemorrhagic shock |
| 03/13/2002 | EP1185291A2 Therapeutic agent comprising a botulinum neurotoxin |
| 03/13/2002 | EP1185289A2 Amino acids from fish and soy proteins for improvement of insulin sensitivity |
| 03/13/2002 | EP1185288A1 Hemoactive compositions and methods for their manufacture and use |
| 03/13/2002 | EP1185286A1 Mu o-conopeptides and their use as local anesthetics |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185283A1 Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection |
| 03/13/2002 | EP1185279A2 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 03/13/2002 | EP1185260A1 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 03/13/2002 | EP1185248A2 Supercritical fluid-assisted nebulization and bubble drying |
| 03/13/2002 | EP0986394B1 Anti-coagulation of blood, blood plasma or synovial fluid products |
| 03/13/2002 | EP0915668B1 Drinkable, acid nutrient composition with long shelf life and health-promoting action |
| 03/13/2002 | EP0907349B1 Compositions for the removal of dental plaque |
| 03/13/2002 | EP0874634B1 Control of healing process |
| 03/13/2002 | EP0869805B1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 03/13/2002 | EP0833573B1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 03/13/2002 | EP0826058B1 Chimeric mcp and daf proteins with cell surface localizing domain |
| 03/13/2002 | EP0725135B1 Gene that codes for polypeptide having ability to support pre-b cell proliferation |
| 03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
| 03/13/2002 | EP0673652B1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 03/13/2002 | EP0672118B1 A novel b-lymphoma cell line and antigen |
| 03/13/2002 | EP0600010B1 USE OF RELAXIN for the manufacture of a medicament for the treatment of CARDIOVASCULAR diseases. |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340102A Polypeptide variants with raised heparin-binding capacity |
| 03/13/2002 | CN1340060A Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 03/13/2002 | CN1340059A Peptides |
| 03/13/2002 | CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/13/2002 | CN1340057A Synthetic poly peptide disturbing intracelluler signaling |
| 03/13/2002 | CN1339973A Gene therapy for diabetic ischemic disease |
| 03/13/2002 | CN1339962A Stable non-aqueous single phase viscons vehicles and formulations utilizing such vehicles |
| 03/13/2002 | CN1339944A Organoprotective solutions |
| 03/13/2002 | CN1339603A New polypeptide-human 26S proteasome regulating subunit 64.35 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339602A New polypeptide-dipeptide amino peptidase IV relative protein (DPPX) 52.14 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339601A New polypeptide-nitrilase 30.36 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339600A New polypeptide-human palmityl protein thioesterase 2-21.12 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339599A New polypeptide-phosphotadic acid phosphatase 29.81 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339598A New polypeptide-human ATP dependent RNA spiral enzyme 20.24 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339597A New polypeptide-human phosphatidase A2-activator protein 9.68 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339596A New polypeptide-human protein typrosine phosphatase 10.67 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339595A New polypeptide-protein kinase c47.52 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339594A New polypeptide-receptor tyrosine kinase HEK 8.91 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339593A New polypeptide-serine/threonine protein kinase MO1518.48 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339592A New polypeptide-protein arginine N-methyltransferase -1(PRMT1) 11.44 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339591A New polypeptide-arachidonic acid epoxidase 42.46 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339590A New polypeptide-human dehydroggenase 29.15 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339589A New polypeptide-human valyl tRNA synthetase 33 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339588A New polypeptide-NRD2 converzyme 56.98 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339587A New polypeptide-human chalcone and diphenyl ethylene synthase 9.57 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339489A New polypeptide-human retinoic acid modulator protein 53.57 and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339456A New polypeptide-membrane-spanning protein 35.31 with epidermal growth factor liker repeating functional domain and polynucleotide for encoding such polypeptide |
| 03/13/2002 | CN1339319A Medicine for treating AIDS and its preparing method |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/13/2002 | CN1080575C Conjugation-stablized polypeptide compositions, therapeutic delivery and disgnostic formulations comprising same, and method of making and using the same |
| 03/12/2002 | US6355809 Method for preparing (2s)-1-(2r3s)-5-chloro-3-(2-chlorophenyl) -1-(3,4-dimethoxy benzene-sulphonyl) 3-hydroxy-2,3-dihydro-1h-indole-2-carbonyl pyrrolidine-2-carboxamide |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355790 Inhibition of HIV replication using a mutated transfer RNA primer |
| 03/12/2002 | US6355789 Cloned dna sequences related to the entire genomic rna of human immunodeficiency virus ii (hiv-2), polypeptides encoded by these dna sequences and use of these dna clones and polypeptides in diagnostic kits |
| 03/12/2002 | US6355788 A polynucleotide encoding a protein that regulates tumor growth factors; diagnosis and therapy for atherosclerosis; understand gonadal pituitary hypothalamic regulation, tooth and bone formation, spermatogenesis, and differentiation |
| 03/12/2002 | US6355785 Enzyme inhibitors |
| 03/12/2002 | US6355780 Death domain modulators; tumor and cancer therapy; therapy for eating disorders, hepatitis, inflammatory disease, liver disorders and rheumatic diseases |
| 03/12/2002 | US6355779 An antibody member from the tumor necrosis factor receptor super family; cancer therapy, understanding immune responses |
| 03/12/2002 | US6355777 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
| 03/12/2002 | US6355774 Isolated p27 protein |
| 03/12/2002 | US6355690 Remedy for CAG repeat expansion diseases |
| 03/12/2002 | US6355684 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355626 Antithrombin agents in treatment of asthma |
| 03/12/2002 | US6355622 Use of a melanoma differentiation associated gene (mda-7) for inducing apoptosis of a tumor cell |
| 03/12/2002 | US6355621 Antigenomic oligodeoxynucleotides for treatment of infection by negative-stranded nonsegmented RNA viruses |
| 03/12/2002 | US6355619 Chemokines to cognate alpha-chemokine receptors and antitumor agents |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355617 Peptide derivatives |
| 03/12/2002 | US6355616 Derivative compounds derived from or based on bactericidal/permeability-increasing protein |
| 03/12/2002 | US6355613 Cyclized oligopeptides with bridging groups of amide, thioether, thioester or disulfide |
| 03/12/2002 | US6355612 Protein material for slow digestion and its use |
| 03/12/2002 | US6355611 Salt form of a conjugate useful in the treatment of prostate cancer |
| 03/12/2002 | US6355610 Inhibitors of formation of protease resistant prion protein |
| 03/12/2002 | US6355486 Geenerating genetically engineered microorganism; mix microorganism and preferential nucleotide sequences, electroporate mix, recover genetically engineered microorganism |
| 03/12/2002 | US6355484 Methods and compositions for polypeptides engineering |
| 03/12/2002 | US6355483 Antisense nucleotides for use in the treatment of leukemia |
| 03/12/2002 | US6355482 Oligonucleotide sequences for use in gene therapy |
| 03/12/2002 | US6355480 Nucleotide sequences which code preferential protein for use in the treatment of fertility and cell proliferation defects |
| 03/12/2002 | US6355479 Insect polypeptide for use in the treatment of autoimmune diseases, allergies and cancer |
| 03/12/2002 | US6355477 Fibronectin and fibrinogen binding protein from group A streptococci |
| 03/12/2002 | US6355468 Purified from rhodotolura yeast extract; phenylalanine production |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |